Financhill
Back

PIMCO Income Strategy Fund II Vs. Neurogene Industry Stock Comparison

Sell
44

PFN
PIMCO Income Strategy Fund II

Last Price:
7.42
Seasonality Move:
0.99%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
44
PIMCO Income Strategy Fund II (PFN) is a Sell

Is PIMCO Income Strategy Fund II a Buy, Sell or Hold?

  • The current PIMCO Income Strategy Fund II [PFN] share price is $7.41. The Score for PFN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • PFN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PFN Stock Price Chart

What is PIMCO Income Strategy Fund II's stock price today?

  • The PIMCO Income Strategy Fund II share price today is $7.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PFN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

PFN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 33.57 Sell
Chaikin Money Flow: 298708 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.47 - 7.57) Sell
Bollinger Bands (100): (7.2 - 7.56) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

PFN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.5 Sell
20-day SMA: 7.51 Sell
50-day SMA: 7.54 Sell
200-day SMA: 7.37 Buy
8-day EMA: 7.47 Sell
20-day EMA: 7.51 Sell
50-day EMA: 7.5 Sell
200-day EMA: 7.36 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

PIMCO Income Strategy Fund II Earnings Growth & PFN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

PIMCO Income Strategy Fund II Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):